Dec
04

Alexandria Wins Nod for Merck R&D Project

By
The REiT will develop a 294,000-square-foot, LEED-Platinum facility in South San Francisco for the pharmaceutical giant.

Alexandria will develop an R&D facility for Merck in South San Francisco.Alexandria will develop an R&D facility for Merck in South San Francisco.

South San Francisco – Merck Research Laboratories, the research arm of global biopharmaceutical company Merck & Co., has chosen Alexandria Real Estate Equities Inc. to develop, construct and operate its new West Coast research facility in South San Francisco, Calif.

Merck signed a long-term, full-building lease for a nine-story, 294,000-square-foot laboratory/office campus at 213 East Grand Ave. in the South San Francisco innovation cluster. The campus site is fully entitled so construction is expected to begin in early 2017 and be completed by early 2019. The cost of the development and lease terms were not released…

Alexandria Wins Nod for Merck R&D Project

Share
Categories : Uncategorized

Leave a Reply

You must be logged in to post a comment.